Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Orexigen Therapeutics, Inc. (NQ: OREX)
6.430 USD  +0.240 (+3.88%)
Streaming Delayed Price  /  Updated: 10:34 AM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 372,470
Open 6.100
Bid (Size) 6.430 (3000)
Ask (Size) 6.440 (500)
Prev. Close 6.190
Today's Range 6.020 - 6.470
52wk Range 3.100 - 7.730
Shares Outstanding 94,642,128
Dividend Yield N/A
Featured News
More News
Six Things to Watch at Biotech CEO Conference
February 11, 2013
Dozens of fund managers will be sizing up biotech executives over the next couple of days in New York. More than 100 public companies are scheduled to speak at the Bio CEO & Investor Conference which... Read More
from Minyanville Headlines
Vivus, Arena, Orexigen Get a Bounce After Aetna Says It Will Cover Diet Pills
November 21, 2012
MINYANVILLE ORIGINAL Aetna (NYSE:AET) one of the country’s largest health insurers says a pair of recently approved diet pills are medically necessary boosting the stocks of three weight-loss drug... Read More
from Minyanville Headlines

Featured News
Read More
Will Diet Pill Maker Orexigen Benefit From Vivus' Troubles?
November 09, 2012
from Minyanville Headlines
Buy or Sell? Wednesday's Winners: GWRE, OREX
September 06, 2012
from Investopedia Advisor Commentary
Thursday’s biggest gaining and declining stocks
September 06, 2012
category Computer Software , Retail , Transportation , and 21 more.
from MarketWatch
Wednesday’s biggest gaining and declining stocks
September 05, 2012
category GWRE , Computer Software , Biotechnology , and 14 more.
from MarketWatch
Vivus surges, Arena falls after diet drug OK
July 18, 2012
category Market News , CH:ROG , Biotechnology , and 9 more.
from MarketWatch
Wednesday’s biggest gaining and declining stocks
July 11, 2012
category Market News , Computer Software , ANF , and 12 more.
from MarketWatch
More News
Read More
Orexigen Therapeutics Earnings Review: 12 Days after Announcement Shares Up 0.7% (OREX)
May 20, 2013
from Comtex SmarTrend® News Briefs
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
May 17, 2013
from PR Newswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Orexigen Therapeutics, Inc.
May 13, 2013
from Business Wire News Releases
Why Does Arena's Obesity Drug Have Abuse Potential?
May 11, 2013
category TOKYO:ESALY , NASDAQ:OREX , NASDAQ:ARNA , and 1 more.
from Forbes Real Time
Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 10, 2013
from PR Newswire
Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
May 08, 2013
from PR Newswire
Will The Prescription Diet Pill Market Finally Bulk Up?
May 08, 2013
category NASDAQ:OREX , NASDAQ:ARNA , NASDAQ:VVUS
from Forbes Real Time
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Orexigen Therapeutics, Inc.
May 07, 2013
from PR Newswire
MDT, HLF, OREX, and NVS Early Briefing and Review
May 06, 2013
from ACCESSWIRE
VIVUS, Inc. (VVUS) Ticks Higher as Arena (ARNA) Pulls BELVIQ MAA in Europe
May 03, 2013
from StreetInsider.com News Articles
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
Mother of All Fed Cha Cha Days or Last Tango on Wall Street?
Jeffrey Cooper
2
Stock Upgrades: Mystic Meg Predicts Profits at Hewlett-Packard
Justin Sharon
3
Random Thoughts: Can the S&P Trade to 1500?
Todd Harrison
4
Pre-Market Primer: Fed Triggers a Stock Bloodbath; Initial Claims Fall
Vincent Trivett
5
Stock Downgrades: A Farewell to ARM Holdings
Justin Sharon